Drug-Free Wireless Pain Relief Neurostimulator Changing Lives for Sufferers of Chronic Pain

BLAINVILLE, Quebec--(BUSINESS WIRE)-- Statistics Canada says six million people across the country suffer from chronic pain, meaning about 20 per cent of the population is affected. Everyone knows someone suffering from chronic pain and how debilitating it can be, but neurostimulation is changing many lives and offering a drug free alternative for pain management.

While implantable neurostimulation has been approved by Health Canada for a decades, what’s different about Stimwave is the small size– Stimwave’s Freedom SCS System is the world’s first wireless, fully-programmable SCS neuromodulation device providing a life-changing technological breakthrough for chronic pain patients. The Freedom stimulators are designed to be a less-invasive alternative, typically that would otherwise warrant surgery to place paddles leads or large IPGs, which have been reported to have substantial complications in at least a third of all patients.

The Freedom SCS System is Health Canada licensed and commercially available in Canada for Spinal Cord Stimulation at frequency parameters up to 10 000 Hz. The safety and effectiveness of the Freedom SCS System was demonstrated by the SURF RCT STUDY that will soon be published in Pain Medicine.

With the Stimwave technology, only a small device with electrode contacts and an embedded chip, and tiny wire receiver is placed within the body, reducing complexity and potential for complications with the first minimally-invasive, outpatient procedure, enabling a lower cost option for Health Care Systems and Canadian Tax Payers.

The Stimwave electroceutical permanent device contains no internal batteries or other toxic materials and is 95 percent smaller than the smallest available implantable battery. The system features the ability to deliver up to 10 000 Hz waveforms, as well as provides all treatments paradigms to every patient (i.e: tonic, burst and high frequency) and allows the patient to have a whole body 3T or 1.5T MRIs without removing the implant or restricting scan times, which is unique in the industry.

Budgets are available in many hospitals and many third-party payers pay for this solution. Talk to your doctor or contact us at info@stimwave.ca for more information.

About Stimwave

Stimwave Technologies Incorporated is a privately held medical device company engaged in the development, manufacture, and commercialization of wirelessly powered, injectable, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective pain management solution that is easily incorporated into their daily lives. Stimwave’s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of pain management. www.stimwave.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20190321005126/en/